Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -7.2% | -7.3% | 1 / 3 | +1.9% | +0.78 pp | -0.35 pp | +15.5% | 0.00 | 11.99 | 240 | +1,9% | 8,5 | −7,2% | 11.99 | 13.17 | −8,9% |
| Pts | 0 | 0 | 4 | 0 | 8 | 4 | 4 | 12 | 8 | |||||||
Valuation annotation:Price: 30.600 (close price on 2026-10-13)EPS (TTM): 2.551
Financial charts
1.Revenue & growth
VND bn240Q2/26
1.Revenue & growth
VND bn240Q2/26
2.Profit & growth
VND bn8,47Q2/26
3.Profit mix (Penman)
VND bn38,4Q2/26
4.Margins & cost structure
%32.5%Q2/26
5.Returns & cash cycle
% · days21.3%Q2/26
6.Earnings quality & cash
VND bn57,3Q2/26
7.Asset structure
VND bn334Q2/26
8.Funding & debt health
VND bn · times334Q2/26
9.Revenue backlog
VND bn1,62Q2/26
10.Valuation
times · %12,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %777Q2/26
Adjusted EPS growth, latest quarter
-7.2%
Average adjusted EPS growth, 3 quarters
-7.3%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26